Goldman Sachs Group »

Kala Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Kala Pharmaceuticals (KALA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.4k 14k 0.17

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Tesla CMN (TSLA)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN (HYG)
Taiwan Semiconductor Manufac CMN (TSM)

View all positions for Goldman Sachs Group

Top funds holding Kala Pharmaceuticals

Citadel Advisors
Geode Capital Management
ADAR1 Capital Management
Vanguard Group
Virtu Financial
GSA Capital Partners
UBS Group
Vanguard Capital Management
Renaissance Technologies
Jane Street
Vanguard Fiduciary Trust
State Street Corporation
XTX Topco
Grant Private Wealth Management
Greenwich Wealth Management

View all funds holding Kala Pharmaceuticals